ANSEA was represented at the ACCESS Forum US’25 in Austin, held on June 8–10, 2025: aptly named as “the Davos of Access, where global access strategies are born, debated, and launched.”
Our MD, Mr Anand Jha, showcased our capabilities and engaged with the top minds in Market & Patient Access, MedTech, HEOR, and Health Policy to debate on the hottest access challenges being thrown upon the industry. The range of topics included – the US Access & Pricing Issues – IRA/MFN, CMS Price Negotiations, EU HTAR / JCA dynamics, AI in Market Access, Future Market Access function and emerging capabilities, HEOR structure to drive access, capturing the value of RWE in product story, commercializing CART & Gene Therapies and building Value & Access Capabilities in MedTech.
ANSEA continues to participate in key healthcare conferences with its commitment to enhancing patient access for novel therapies and contributing to policy shaping activities support this objective.
